Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Meltzer, Martin
and
Messonnier, Mark L.
1999.
Economic models of hepatitis a virus immunization.
Hepatology,
Vol. 30,
Issue. 1,
p.
343.
Das, Ananya
1999.
An economic analysis of different strategies of immunization against hepatitis a virus in developed countries.
Hepatology,
Vol. 29,
Issue. 2,
p.
548.
Stone, Patricia W.
Teutsch, Steven
Chapman, Richard H.
Bell, Chaim
Goldie, Sue J.
and
Neumann, Peter J.
2000.
Cost-utility analyses of clinical preventive services11The full text of this article is available via AJPM Online at http://www.elsevier.com/locate/ajpmonline..
American Journal of Preventive Medicine,
Vol. 19,
Issue. 1,
p.
15.
Myers, Robert P.
Gregor, James C.
and
Marotta, Paul J.
2000.
The cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C.
Hepatology,
Vol. 31,
Issue. 4,
p.
834.
Berge, Jeremy J.
Drennan, David P.
Jacobs, R. Jake
Jakins, Alan
Meyerhoff, Allen S.
Stubblefield, Wayne
and
Weinberg, Melvyn
2000.
The cost of hepatitis A infections in American adolescents and adults in 1997.
Hepatology,
Vol. 31,
Issue. 2,
p.
469.
Saab, Sammy
Martin, Paul
and
Yee, Hal F
2000.
A simple cost-decision analysis model comparing two strategies for hepatitis A vaccination.
The American Journal of Medicine,
Vol. 109,
Issue. 3,
p.
241.
Chodick, Gabriel
Lerman, Yehuda
Peled, Tamar
Aloni, Hava
and
Ashkenazi, Shai
2001.
Cost-Benefit Analysis of Active Vaccination Campaigns Against Hepatitis A Among Daycare Centre Personnel in Israel.
PharmacoEconomics,
Vol. 19,
Issue. 3,
p.
281.
André, Francis
Van Damme, Pierre
Safary, Assad
and
Banatvala, Jangu
2002.
Inactivated hepatitis A vaccine: immunogenicity, efficacy, safety and review of official recommendations for use.
Expert Review of Vaccines,
Vol. 1,
Issue. 1,
p.
9.
Chodick, Gabriel
Lerman, Yehuda
Wood, Francis
Aloni, Hava
Peled, Tamar
and
Ashkenazi, Shai
2002.
Cost-Utility Analysis of Hepatitis A Prevention Among Health-Care Workers in Israel.
Journal of Occupational and Environmental Medicine,
Vol. 44,
Issue. 2,
p.
109.
Jacobs, R Jake
Moleski, Ronald J.
and
Meyerhoff, Allen S.
2002.
Valuation of Symptomatic Hepatitis A in Adults.
PharmacoEconomics,
Vol. 20,
Issue. 11,
p.
739.
Jacobs, R. Jake
Koff, Raymond S.
and
Meyerhoff, Allen S.
2002.
The cost-effectiveness of vaccinating chronic hepatitis C patients against hepatitis A1.
The American Journal of Gastroenterology,
Vol. 97,
Issue. 2,
p.
427.
Duncan, Marten
Hirota, William K
and
Tsuchida, Amy
2002.
Prescreening Versus Empirical Immunization for Hepatitis A in Patients With Chronic Liver Disease: A Prospective Cost Analysis.
American Journal of Gastroenterology,
Vol. 97,
Issue. 7,
p.
1792.
Rosenthal, P
2003.
Cost-effectiveness of hepatitis A vaccination in children, adolescents, and adults.
Hepatology,
Vol. 37,
Issue. 1,
p.
44.
JACOBS, R. JAKE
GREENBERG, DAVID P.
KOFF, RAYMOND S.
SAAB, SAMMY
and
MEYERHOFF, ALLEN S.
2003.
Regional variation in the cost effectiveness of childhood hepatitis A immunization.
The Pediatric Infectious Disease Journal,
Vol. 22,
Issue. 10,
p.
904.
Jacobs, R. Jake
Gibson, Gene A.
and
Meyerhoff, Allen S.
2004.
Cost-Effectiveness of Hepatitis A–B Vaccine Versus Hepatitis B Vaccine for Healthcare and Public Safety Workers in the Western United States.
Infection Control & Hospital Epidemiology,
Vol. 25,
Issue. 7,
p.
563.
Van Herck, Koen
and
Van Damme, Pierre
2005.
Prevention of hepatitis A by Havrix™: a review.
Expert Review of Vaccines,
Vol. 4,
Issue. 4,
p.
459.
Chodick, G.
Ashkenazi, S.
and
Lerman, Y.
2006.
The risk of hepatitis A infection among healthcare workers: a review of reported outbreaks and sero-epidemiologic studies.
Journal of Hospital Infection,
Vol. 62,
Issue. 4,
p.
414.
Luyten, Jeroen
and
Beutels, Philippe
2009.
Costing Infectious Disease Outbreaks for Economic Evaluation.
PharmacoEconomics,
Vol. 27,
Issue. 5,
p.
379.
Jung, S.-I.
Lee, C.-S.
Park, K.-H.
Kim, E.S.
Kim, Y.J.
Kim, G.S.
Lim, D.S.
Moon, J.E.
Min, J.J.
Bom, H.S.
Jung, M.-H.
Chang, Y.J.
Chae, S.L.
and
Lee, J.H.
2009.
Sero-epidemiology of hepatitis A virus infection among healthcare workers in Korean hospitals.
Journal of Hospital Infection,
Vol. 72,
Issue. 3,
p.
251.
Luyten, Jeroen
Van de Sande, Stefaan
de Schrijver, Koen
Van Damme, Pierre
and
Beutels, Philippe
2012.
Cost-effectiveness of hepatitis A vaccination for adults in Belgium.
Vaccine,
Vol. 30,
Issue. 42,
p.
6070.